STAT

DECEMBER 11, 2024

Eli Lilly, which has been directing patients to various telehealth sites as it sells its blockbuster obesity medication Zepbound, is broadening its reach, announcing a partnership Wednesday with major telehealth platform Ro Health. Under the new agreement, patients will be able to order vials of Zepbound through Ro’s app. Previously, Lilly had only made these vials, which are priced lower than its injectable pens, available to patients with prescriptions ordering directly through an onlin

Compounding 330

Compounding Compounding Pharmacies 330

PharmaVoice

DECEMBER 4, 2024

Dr. Marty Makary’s conflicts of interest could come into question before he is confirmed as the next FDA commissioner.

264

264

ALiEM - Pharm Pearls

DECEMBER 20, 2024

A 3-year-old male with a history of severe atopic dermatitis presented for facial rash and hand pain. Mom had been applying Aquaphor and Vaseline several times a day. On the day of presentation, he woke up with a new rash over his face and hands which prompted the ED visit. He is up to date on childhood immunizations and is not prescribed any oral medications.

Immunization 130

Immunization Immunity 130

Express Pharma

DECEMBER 2, 2024

In recent years, GLP-1 receptor (GLP-1R) products have gained immense popularity. Currently, four innovative GLP-1Rs are approved worldwide for obesity, all of which are injectables. This leaves a gap in the obesity market for an oral GLP-1R product. 63 drugs are in active development, with four Phase III products racing to earn the inaugural approval in this untapped market, says GlobalData.

Labelling 126

Labelling Diabetes Drug Development 126

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

The Pharmacist

DECEMBER 3, 2024

Fake online pharmacies are targeting vulnerable patients whose medicines are in short supply, including obesity drugs, ADHD medication and hormone replacement therapy (HRT), the Royal Pharmaceutical Society (RPS) has reported. The Medicines and Healthcare products Regulatory Agency (MHRA) said such fraudulent supply was the work of 'organised criminal gangs', while the General Pharmaceutical (GPhC) warned […] The post 'Concerning reports' of scam websites targeting weight loss an

Online Pharmacies 116

Online Pharmacies 116

Pharma Times

DECEMBER 11, 2024

Promising results set stage for European marketing authorization

127

127

PharmaVoice

DECEMBER 2, 2024

Intrinsic Medicines is entering phase 2 trials in Parkinson’s disease and IBS for its human milk oligosaccharide drug candidates next year.

246

246

ALiEM - Pharm Pearls

DECEMBER 13, 2024

An 87-year-old female with a history of hypertension, hyperlipidemia, chronic kidney disease stage IIIB, type 2 diabetes mellitus, and schizophrenia presented for evaluation due to sudden visual loss in her right eye, which began 12 hours before she arrived at the emergency department. She has experienced a sudden loss of vision in her right eye for more than six hours.

Diabetes 130

Diabetes 130

pharmaphorum

DECEMBER 4, 2024

Genmab has licensed another anti-glycan antibody for cancer from UK biotech Scancell as it continues to expand its in-house pipeline.

129

129

The Pharmacist

DECEMBER 2, 2024

The lowest monthly total of minor illness referrals yet have been recorded for August, according to latest Pharmacy First data for England. Some 87,405 claims for minor illness consultations in August were submitted to, processed and published by the NHS Business Services Authority (NHSBSA) by 25 November. This was nearly 50,000 fewer than those recorded […] The post GPs made fewer Pharmacy First minor illness referrals in August, data suggests appeared first on The Pharmacist.

123

123

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

Express Pharma

DECEMBER 20, 2024

Indias life sciences industry continues to demonstrate its stature as a global powerhouse, often referred to as the pharmacy of the world. Renowned for its extensive production of generic drugs and vaccines, the sector has played a pivotal role in addressing global healthcare demands. As of 2024, India has produced nearly half of the eight billion vaccine doses distributed worldwide, cementing its reputation as a reliable healthcare contributor.

Biosimilars 101

Biosimilars Vaccines 101

STAT

DECEMBER 12, 2024

Like many Americans, Holden Karau said she was fed up with health insurance. The software engineer’s disillusionment began in 2019, when her insurer, UnitedHealthcare, balked at covering physical therapy after she was hit by a car and could not walk. She said the hassles piled on stress, forced her to pay more out of pocket, and delayed access to care she needed to recover from multiple broken bones.

353

353

PharmaVoice

DECEMBER 4, 2024

Four companies that refreshed their mission and public persona with a new look.

225

225

BioPharma Dive

DECEMBER 4, 2024

Results from the head-to-head study showed treatment with Zepbound resulted in 47% greater relative weight loss than Wegovy, a finding that could advantage Lilly in the companies’ market competition.

126

126

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

EMCrit Project

DECEMBER 1, 2024

John Holcomb, author of the PROPPR trial, on massive transfusion in 2024 EMCrit Project by Scott Weingart, MD FCCM.

126

126

The Pharmacist

DECEMBER 9, 2024

A new, confidential, 24/7 text support service has been launched to support healthcare workers 'who may have had a tough day, are feeling worried or overwhelmed, or have a lot on their mind and need to talk it through'. The NHS England (NHSE) support offer will extend to all staff, including community pharmacists and their […] The post New helpline to support pharmacists 'feeling worried or overwhelmed' appeared first on The Pharmacist.

123

123

pharmaphorum

DECEMBER 3, 2024

The MHRA has reminded pharma companies that from 1st January all medicines sold in the UK will have to comply with new labelling requirements

Labelling 124

Labelling 124

STAT

DECEMBER 10, 2024

The Ohio Supreme Court ruled that three of the largest pharmacy chain operators in the U.S. could not be held liable under a state nuisance law for contributing to the long-running opioid crisis. In a 5-to-2 vote, the court determined that the law barred two Ohio counties from obtaining a $650.9 million judgement that was won in a federal court against CVS Health, Walgreens, and Walmart.

358

358

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

PharmaVoice

DECEMBER 20, 2024

The high drama of an election year, industry layoffs, patent cliff strategies and other key trends that shaped pharma in 2024.

147

147

Express Pharma

DECEMBER 11, 2024

Dr. Reddy’s Laboratories has recently become the first Indian company to launch checkpoint inhibitor Zytorvi (toripalimab) in collaboration with Shanghai Junshi Biosciences. Zytorvi is an immuno-oncology therapy for recurrent or metastatic nasopharyngeal carcinoma (RM-NPC). This marks a transformative moment, bringing a next-generation PD-1 inhibitor to India and addressing significant unmet medical needs.

Biosimilars 103

Biosimilars Chemotherapy 103

Pharma Times

DECEMBER 5, 2024

New antibody therapy shows promise in managing condition

123

123

The Pharmacist

DECEMBER 10, 2024

Non-clinical pharmacy managers in England could come under the scope of regulation proposals launched by the Department of Health and Social Care (DHSC). Itspublic consultation sets out measures that aim to increase accountability of NHS managers and leaders, and set clear and consistent professional standards, including a potential regulatory system.

Pharmacy Management 111

Pharmacy Management 111

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

Pharmaceutical Technology

DECEMBER 9, 2024

Shares in WuXi AppTec, one of those implicated in the Chinese biotech blacklisting legislation, surged following the omission.

120

120

STAT

DECEMBER 12, 2024

During 2023, drugmakers substantially raised prices on five widely used medicines without any new clinical evidence to justify the increases, leading patients and health insurers in the U.S. to spend an additional $815 million last year, according to a new report. The drug for which spending increased the most due to a price increase was Biktarvy, which is prescribed to treat HIV and is a franchise product for Gilead Sciences.

Drug Pricing 312

Drug Pricing 312

PharmaVoice

DECEMBER 11, 2024

The agency has yet to make a decision about keeping tirzepatide on or off of its shortage list — letting compound pharmacies continue their lucrative operations for now.

Compounding 162

Compounding Compounding Pharmacies 162

BioPharma Dive

DECEMBER 2, 2024

The ADA recommended doctors avoid prescribing unapproved, off-brand versions of drugs like Wegovy, wading into a dispute that has gripped the FDA and compounding pharmacies over the past few months.

Compounding 122

Compounding Compounding Pharmacies Diabetes 122

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Pharma Times

DECEMBER 2, 2024

Race to create first oral drug for obesity intensifies

124

124

The Pharmacist

DECEMBER 12, 2024

New Pharmacy First analysis has suggested pharmacists are treating antimicrobial stewardship with utmost importance and only supplying antibiotics when appropriate. On average, two-thirds (66%) of patients attending pharmacies for earaches, bladder infections, sore throats, sinusitis, infected insect bites or impetigo are provided antibiotics, according to a new report by the Company Chemists Association (CCA).

120

120

Express Pharma

DECEMBER 15, 2024

The All India Pharmaceutical Associations Consortium (AIPAC) launched its first programme for Micro, Small, and Medium Enterprises (MSMEs) in the pharmaceutical sector on 12 December 2024. The event took place at the Prestige Institute of Management & Research, Indore, and was inaugurated by Dr Rajeev Singh Raghuvanshi, the Drugs Controller General of India (DCGI), Central Drugs Standard Control Organization (CDSCO).

Pharmaceutical Manufacturing 102

Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 102

STAT

DECEMBER 11, 2024

A proposed Senate bill that would prohibit companies that control health insurers or pharmacy benefit managers from owning pharmacies rattled investors on Wednesday, but some Wall Street analysts believe the legislation is unlikely to gain much traction, at least for now. The bipartisan bill , which would require divestiture within three years, is aimed at what the lawmakers call an “inherent conflict of interest” that has forced Americans to pay more for medicines and hastened the

Independent Pharmacies 331

Independent Pharmacies Drug Pricing 331

PharmaVoice

DECEMBER 20, 2024

The FDA’s decision will close a lucrative market opportunity for compounding pharmacies, although the agency will give a limited grace period before taking any enforcement actions.

Compounding Pharmacies 130

Compounding Pharmacies Compounding 130